CLINICAL_TRIALS
trial_result
· 2023-11-28
Clinical Trial Update: A Study of LY3451838 in Participants With Migraine [Phase 2]
Summary
A Phase 2 study of LY3451838 in participants with migraine has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Migraine | Phase 2 | Status: COMPLETED | Results posted: 2023-11-28